Welcome to our dedicated page for Perceptive Capital Solutions SEC filings (Ticker: PCSC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Perceptive Capital Solutions Corp (PCSC) is a special purpose acquisition company in the Financial Services sector, listed on The Nasdaq Global Market under the ticker PCSC. It is described as a blank check company formed for the purpose of entering into a combination with one or more businesses or entities, with an intended focus on healthcare in the United States and other developed countries.
This SEC filings page is designed to help users review the regulatory record associated with PCSC’s SPAC activities. Although specific filings are not listed in the provided data, public communications indicate that PCSC’s securities were registered with the U.S. Securities and Exchange Commission in connection with its initial public offering of Class A ordinary shares. The registration statement for that offering was declared effective by the SEC, and the company notes that the offering was made only by means of a prospectus filed with the Commission.
In connection with its announced business combination with Freenome Holdings, Inc., PCSC has stated that it intends to file a registration statement on Form S-4 with the SEC. That filing is expected to include preliminary and definitive proxy statements for PCSC shareholders and a prospectus relating to the securities to be issued to Freenome’s stockholders. Additional information about the transaction is also expected to appear in a Current Report on Form 8-K filed by PCSC.
On this page, users can access PCSC’s historical and future SEC submissions, including registration statements, proxy materials and current reports that describe its SPAC structure, risk factors and the terms of its proposed business combination. AI-powered tools on the platform can assist in summarizing long-form documents, clarifying key sections in forms such as S-4 and 8-K, and highlighting information relevant to the evolution of PCSC’s capital structure and its transition to any combined company.
Perceptive Capital Solutions Corp. held an extraordinary general meeting on July 15, 2026, where shareholders approved the Business Combination Proposal with Freenome and related items, including the Domestication Proposal, updated governing documents, Nasdaq listing proposal, an equity incentive plan and an employee stock purchase plan.
Holders of 5,645,461 Class A and 2,156,250 Class B shares, representing approximately 75.65% of voting power as of the June 12, 2026 record date, were present, constituting a quorum. One proposal, for example, received 6,819,879 votes for, 980,832 against and 1,000 abstaining. An adjournment proposal was not needed because the required items had sufficient support.
Perceptive Capital Solutions Corp., a SPAC, reported a small net loss of $166,692 for the six months ended June 30, 2026, versus net income in the prior-year period, driven by higher general and administrative expenses of $1,800,159 and lower investment income from its trust assets. For the quarter, it recorded a net loss of $114,943.
Total assets were $85.8 million, almost entirely the $85.1 million held in the trust account. Cash outside the trust was $437,369, and the company had a working capital deficit of $2,885,923. After the June 10, 2026 extension vote, 754,008 Class A shares were redeemed for about $8.16 million, leaving 7,870,992 Class A shares subject to possible redemption at approximately $10.81 per share.
The deadline to complete a business combination was extended from June 13, 2026 to June 13, 2027, but management states that liquidity constraints and the mandatory liquidation date raise substantial doubt about the company’s ability to continue as a going concern. The company is pursuing a planned merger with Freenome Holdings, Inc. at an implied equity value of $725 million, supported by a committed PIPE financing of 24,000,000 shares of New Freenome common stock at $10.00 per share, or $240 million, expected to close in the second half of 2026 if conditions are met.
Perceptive Capital Solutions Corp filed a prospectus supplement registering up to 82,313,492 shares of common stock in connection with its proposed business combination and domestication to Delaware, after which it will be renamed Freenome, Inc.
The supplement, dated July 9, 2026, revises the extraordinary general meeting to 10:00 a.m. Eastern Time on July 15, 2026, extends the redemption deadline to 5:00 p.m. Eastern Time on July 13, 2026, and permits in-person attendance by reservation. It also adds clinical-validation results for the updated SimpleScreen v2 test, reporting weighted sensitivities of 80.4% for CRC (N=89), 18.2% for advanced precancerous lesions (N=1,570), and 41.9% for APLs with high-grade dysplasia (N=157); specificity was 90%. The supplement states the data are preliminary and management review is ongoing.
Freenome and Perceptive Capital Solutions Corp. disclosed top-line results for SimpleScreen CRC v2 presented July 9, 2026, reporting that the v2 assay met its pre-specified primary and secondary endpoints. The US Census‑adjusted sensitivity for colorectal cancer (CRC) was 80.4% (89 cases, 95% CI 70.2%–87.7%) and for advanced precancerous lesions (APL) was 18.2% (1,570 cases, 95% CI 16.3%–20.4%).
The PREEMPT cohort (evaluables n = 9,070) showed improved APL and high‑grade dysplasia (HGD) detection versus v1 while maintaining CRC sensitivity in line with v1. Modelled lifetime projections per 100,000 screened estimate 9.5% fewer CRC cases and deaths and 7.7% more life‑years gained versus v1.
Freenome Holdings announced top-line results from a pivotal validation study of its updated SimpleScreen™ CRC blood test showing the study met its primary and secondary endpoints. The updated test achieved 80.4% sensitivity for colorectal cancer (CRC) and 18.2% sensitivity for advanced precancerous lesions (APLs); specificity for no findings on colonoscopy was 90%. The study included data from the PREEMPT CRC prospective registrational study of 48,995 adults and analysis cohorts of >85 CRC cases, 1,500 APLs, and 150 APLs with high-grade dysplasia (HGD). Modeling reported a projected 7.7% increase in life-years gained and 9.5% fewer CRC cases and deaths per 100,000 screened versus the first-generation test. Freenome says it plans to submit a supplemental PMA for the next-generation test and notes a $70 million milestone payment to Abbott is conditioned on FDA approval and successful technology transfer.
Perceptive Capital Solutions Corp postponed its Extraordinary General Meeting originally scheduled for July 9, 2026 and will now hold the meeting on July 15, 2026 to allow time to supplement the proxy statement/prospectus and continue proxy solicitation in connection with the proposed business combination with Freenome Holdings, Inc.
The deadline for delivery of redemption demands has been extended to 5:00 p.m. Eastern Time on July 13, 2026. Shares of record as of June 12, 2026 remain entitled to vote. The filing notes the Form S-4 registration statement was declared effective on June 17, 2026.
Perceptive Capital Solutions Corp. is postponing its extraordinary general meeting to vote on the proposed business combination with Freenome. The meeting, originally set for July 9, 2026, will now take place on July 15, 2026 at 10:00 a.m. Eastern Time in New York and via virtual webcast.
The delay is intended to give PCSC and Freenome time to supplement the proxy statement/prospectus with information on recent events and to continue soliciting proxies. PCSC has also extended the deadline for Class A shareholders to submit redemption demands to 5:00 p.m. Eastern Time on July 13, 2026, while maintaining June 12, 2026 as the record date for voting.
Perceptive Capital Solutions Corp filings show Point72-related entities report beneficial ownership of 465,000 shares of Class A Ordinary Shares. The statement, filed as a Schedule 13G, records this position as 5.7% of the class as of July 7, 2026.
The filing is made jointly by Point72 Asset Management, Point72 Capital Advisors Inc., and Steven A. Cohen and notes that Point72 Associates holds the shares and that Point72 Asset Management maintains investment and voting power pursuant to an investment management agreement.
Perceptive Capital Solutions Corp (PCSC) and Freenome Holdings, Inc. announced the Registration Statement on Form S-4 was declared effective by the SEC on June 17, 2026. The filing includes a combined proxy statement/prospectus for the proposed business combination that will be mailed to PCSC shareholders of record as of June 12, 2026.
The business combination is governed by a definitive Business Combination Agreement dated December 5, 2025. Upon closing, PCSC will be renamed Freenome, Inc.. The proxy/prospectus contains information for shareholders to consider when voting on the transaction.
Perceptive Capital Solutions Corp reported that its joint Registration Statement on Form S-4 with Freenome Holdings, Inc., related to their proposed business combination, was declared effective by the SEC on June 17, 2026. This clears a key regulatory step for taking Freenome public via PCSC’s SPAC structure.
The companies have scheduled an extraordinary general meeting of PCSC shareholders for July 9, 2026 to vote on the transaction, using a definitive proxy statement/prospectus mailed to shareholders of record as of June 12, 2026. If closing conditions are met, PCSC will be renamed Freenome, Inc. after the business combination.